166 related articles for article (PubMed ID: 3743614)
1. Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris.
Khurmi NS; Robinson CW; O'Hara MJ; Raftery EB
Eur J Clin Pharmacol; 1986; 30(4):387-92. PubMed ID: 3743614
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris.
Khurmi NS; Raftery EB
Cardiovasc Drugs Ther; 1987; 1(1):81-7. PubMed ID: 3154312
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris.
O'Keefe JC; Maltz MB; Butrous GS; Camm AJ
Eur Heart J; 1986 Oct; 7(10):843-7. PubMed ID: 3539614
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: a multicenter trial.
Sykulski R; Keller N; Storm T; Stokke O; Myhre T; Himanen P; Quitzau K
Cardiovasc Drugs Ther; 1989 Jun; 3(3):427-31. PubMed ID: 2487539
[TBL] [Abstract][Full Text] [Related]
5. Duration of action of tiapamil in stable exercise induced angina.
Maltz MB; Davies DW; Caplin JL; Camm AJ
Eur J Clin Pharmacol; 1987; 32(4):339-42. PubMed ID: 3609110
[TBL] [Abstract][Full Text] [Related]
6. Acute antianginal effect of tiapamil.
Gasic S
Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
[TBL] [Abstract][Full Text] [Related]
7. Long-term tiapamil treatment of patients with angina pectoris.
Salorinne Y; Himberg JJ; Eskelinen E
Clin Cardiol; 1983 Apr; 6(4):171-5. PubMed ID: 6404577
[TBL] [Abstract][Full Text] [Related]
8. Tiapamil and hydrochlorothiazide: a double-blind comparison of two antihypertensive agents.
Storm TL; Badskjaer J; Hammer R; Kögler P
J Clin Pharmacol; 1987 Jan; 27(1):18-21. PubMed ID: 3316301
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic effect of intravenous tiapamil on methylergometrine-induced coronary artery spasm in patients with variant angina: randomized double-blind trial.
Danchin N; Clozel JP; Khalife K; Elkik F; Boulay F; Neimann JL; Cherrier F
Am Heart J; 1985 Apr; 109(4):764-8. PubMed ID: 3885699
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Chest; 1986 Feb; 89(2):260-5. PubMed ID: 3510823
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of tiapamil in patients with mild to moderate essential hypertension.
Lacourcière Y; Carrier M; Toal CB
J Cardiovasc Pharmacol; 1989 Jul; 14(1):166-70. PubMed ID: 2475708
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
[TBL] [Abstract][Full Text] [Related]
13. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction.
Eichler HG; Mabin TA; Commerford PJ; Lloyd EA; Beck W; Opie LH
Circulation; 1985 Apr; 71(4):779-86. PubMed ID: 3882269
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
[TBL] [Abstract][Full Text] [Related]
15. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable effort angina.
Di Pasquale G; Lusa AM; Manini GL; Coluccini M; Bassein L; Pinelli G
Int J Cardiol; 1984 Dec; 6(6):673-88. PubMed ID: 6519841
[TBL] [Abstract][Full Text] [Related]
18. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina.
Khurmi NS; Bowles MJ; Bala Subramanian V; Raftery EB
J Am Coll Cardiol; 1984 Nov; 4(5):908-17. PubMed ID: 6386933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
